NCT02248740

Brief Summary

The aim of this study is to perform a randomized, prospective trial comparing the two current methods of treatment for chronic venous insufficiency related to the Small Saphenous Vein (SSV) to evaluate complications and outcomes for each method, and ultimately, to see if one is superior to the other.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2008

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2014

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 25, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2017

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

February 7, 2019

Completed
Last Updated

February 7, 2019

Status Verified

September 1, 2018

Enrollment Period

8.6 years

First QC Date

September 2, 2014

Results QC Date

February 1, 2018

Last Update Submit

September 11, 2018

Conditions

Keywords

chronic venous insufficiencyvaricose veinsmall saphenous vein

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Recurrent Clinical Symptoms of an Incompetent Small Saphenous Vein After Treatment.

    At 10 years after treatment.

Secondary Outcomes (1)

  • Incidence Rate of Acute Complications

    1 and 6 weeks post intervention.

Other Outcomes (1)

  • Incidence of Pain and Bruising

    During Intervention and post procedure recovery period in clinic, an expected average of 2 hours.

Study Arms (2)

Radiofrequency Ablation

ACTIVE COMPARATOR

Device: ClosureFast radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent small saphenous vein, using this device.

Procedure: Ablation of the incompetent small saphenous vein

Laser Ablation

ACTIVE COMPARATOR

Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent small saphenous vein, using this device.

Procedure: Ablation of the incompetent small saphenous vein

Interventions

For each patient, the Small Saphenous Vein (SSV) will be accessed from the midcalf. After liberal use of tumescent anesthesia, ablation of the incompetent small saphenous vein will be performed. Half the patients will have this procedure performed using the Laser Ablation device and half will be performed using the Radiofrequency Ablation device. They will be randomly assigned to treatment.

Laser AblationRadiofrequency Ablation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with symptomatic chronic venous insufficiency.
  • Patients in whom endovenous thermal ablation is clinically indicated.
  • Have previously undergone at least 6 weeks of conservative treatment with compression stockings (unless they have venous ulcers, recurrent phlebitis, or bleeding varices).
  • Have symptoms secondary to Small Saphenous Vein insufficiency defined as reverse flow in the saphenous vein \>0.5 seconds after calf compression or while standing.

You may not qualify if:

  • Have previously undergone surgery, EVTA, or phlebectomy in that extremity (exclusive of spider vein injections or other cosmetic surface procedures).
  • Have a history of Deep Venous Thrombosis (DVT).
  • Have a history of hypercoaguability disorder.
  • Are pregnant or breastfeeding.
  • Are nonambulatory.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Dr. Malcolm Sydnor
Organization
Virginia Commonwealth Univeristy

Study Officials

  • Malcolm Sydnor, MD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2014

First Posted

September 25, 2014

Study Start

September 1, 2008

Primary Completion

March 29, 2017

Study Completion

March 29, 2017

Last Updated

February 7, 2019

Results First Posted

February 7, 2019

Record last verified: 2018-09

Locations